Published in Lancet on September 10, 1977
Role of nifedipine in treatment of hypertension. Br Med J (Clin Res Ed) (1983) 1.70
Long-term antihypertensive drug treatment and blood pressure control in three hospital hypertension clinics. Br Heart J (1980) 1.49
Captopril for refractory hypertension in patients with chronic renal failure and renal transplantation. J R Soc Med (1981) 1.07
Alopecia areata treated with tropical minoxidil. J R Soc Med (1982) 1.00
Topical minoxidil in the treatment of alopecia areata. Br Med J (Clin Res Ed) (1983) 0.93
Combination therapy with beta-adrenoceptor blockers and calcium antagonists. Br J Clin Pharmacol (1986) 0.91
Effects of cepharanthine and minoxidil on proliferation, differentiation and keratinization of cultured cells from the murine hair apparatus. Arch Dermatol Res (1992) 0.79
Hypertensive encephalopathy. Br Med J (1979) 0.75
Reduction of beta-blocking drugs in hypertensive patients treated with minoxidil. Br Med J (1979) 0.75
Short and long term treatment of essential hypertension with felodipine as monotherapy. Drugs (1987) 0.75
Resistance to -adrenoceptor stimulants (a possible explanation for the rise in ashtma deaths). Br J Pharmacol (1971) 6.11
Mortality and implant revision rates of hip arthroplasty in patients with osteoarthritis: registry based cohort study. BMJ (2012) 5.71
Side effects of hypotensive agents evaluated by a self-administered questionnaire. Br Med J (1973) 5.65
Monitoring adverse reactions to drugs. Br Med J (1977) 4.41
Prognosis of treated hypertension. Changes in life expectancy and causes of death between 1952 and 1967. Q J Med (1970) 3.71
Identification of a new catenin: the tyrosine kinase substrate p120cas associates with E-cadherin complexes. Mol Cell Biol (1994) 3.66
A symptom questionnaire for hypertensive patients. J Chronic Dis (1974) 3.51
Isoprenaline resistance and the use of pressurised aerosols in asthma. Lancet (1968) 3.33
Comparison of cardiorespiratory effects of isoprenaline and salbutamol in patients with bronchial asthma. Br Med J (1970) 3.25
Clinical pharmacology and pharmacokinetics of clonidine. Clin Pharmacol Ther (1976) 3.13
Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev (2008) 2.92
Hydralazine-induced systemic lupus erythematosus: influence of HLA-DR and sex on susceptibility. Lancet (1980) 2.63
Effect of propranolol in mild hypertension. Lancet (1966) 2.57
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Blood concentrations in man of fluorinated hydrocarbons after inhalation of pressurised aerosols. Lancet (1970) 2.48
Prostacyclin is not a circulating hormone in man. Prostaglandins (1982) 2.46
European journals, societies, and meetings. Meetings. Br Med J (1973) 2.46
Incidence of a positive direct coombs test in patients on alpha-methyldopa. Lancet (1966) 2.44
Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin. Br Med J (1980) 2.36
Clinical medicine and research in France. Br Med J (1973) 2.32
Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjects. Lancet (1991) 2.27
Computer-based hypertension clinic records: a co-operative study. Br Med J (1974) 2.24
Intravenously administered isoproterenol sulfate dose-response curves in man. Arch Intern Med (1972) 2.23
Positive direct Coombs tests and antinuclear factor in patients treated with methyldopa. Lancet (1967) 2.22
Circulating catecholamines in exercise and hyperventilation induced asthma. Thorax (1981) 2.22
Randomised controlled trial of computer-held medical records in hypertensive patients. Br Med J (1976) 2.15
Change in symptoms of hypertensive patients after referral to hospital clinic. Br Heart J (1976) 2.13
The metabolic fate of DL(7-3H)isoprenaline in man and dog. Biochem J (1969) 2.06
Chronic jet-lag increases mortality in aged mice. Curr Biol (2006) 2.01
Absorption and metabolism of nicotine from cigarettes. Br Med J (1975) 2.01
Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline. Lancet (1977) 2.01
I. Ophthalmoscopic and circulatory changes in focal retinal ischaemia. Br J Ophthalmol (1966) 1.99
Pharmacokinetics of indoramin in man. Br J Clin Pharmacol (1976) 1.97
Syst-Eur. A multicentre trial on the treatment of isolated systolic hypertension in the elderly: objectives, protocol, and organization. Aging (Milano) (1991) 1.93
Clinical pharmacology of beta-receptor-blocking drugs. Clin Pharmacol Ther (1970) 1.92
Pharmacokinetics and concentration-effect relationships of intervenous and oral clonidine. Clin Pharmacol Ther (1977) 1.91
Assessment of selective beta-adrenoceptor blockade in man. Br J Pharmacol (1973) 1.85
Pathogenesis of hypertensive retinopathy. An experimental study in the monkey. Br J Ophthalmol (1975) 1.79
Rifampicin and vitamin D metabolism. Clin Pharmacol Ther (1980) 1.78
Clinical evaluation of indoramin, a new antihypertensive agent. Eur J Clin Pharmacol (1973) 1.78
The drug treatment of hypertension. Practitioner (1971) 1.75
Glucose intolerance in hypertensive patients treated with diuretics; a fourteen-year follow-up. Lancet (1982) 1.73
Experimental retinal branch vein occlusion. Am J Ophthalmol (1970) 1.72
Role of nifedipine in treatment of hypertension. Br Med J (Clin Res Ed) (1983) 1.70
Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm. J Physiol (1989) 1.68
Urinary leukotriene E4 after antigen challenge and in acute asthma and allergic rhinitis. Lancet (1989) 1.66
Prostaglandin D2 potentiates airway responsiveness to histamine and methacholine. Am Rev Respir Dis (1986) 1.65
Serum-insulin in essential hypertension and in peripheral vascular disease. Lancet (1966) 1.61
Editorial: Pharmacokinetics--master or servant? Eur J Clin Pharmacol (1973) 1.57
Brain concentration of propranolol in relation to hypotensive effect in the rabbit with observations on brain propranolol levels in man. J Pharmacol Exp Ther (1975) 1.56
Clinical pharmacology of beta-reccer-atefoygolocarahp lnilcc clinical pharmacology of beta-receptor-blocking drugs. Clin Pharmacol Ther (1969) 1.56
Alveolar gas concentrations of fluorocarbons-11 and-12 in man after use of pressurized aerosols. Thorax (1974) 1.52
THE X-RAYS. Science (1896) 1.50
Heparin kinetics in venous thrombosis and pulmonary embolism. Circulation (1976) 1.50
Long-term antihypertensive drug treatment and blood pressure control in three hospital hypertension clinics. Br Heart J (1980) 1.49
Measurement of 6-oxo-PGF1 alpha in human plasma using gas chromatography-mass spectrometry. Prostaglandins (1979) 1.48
Increased pulmonary alpha-adrenergic and reduced beta-adrenergic receptors in experimental asthma. Nature (1980) 1.46
Measurement of plasma histamine in asthma. Clin Allergy (1983) 1.46
Effect of enalapril on the skin response to bradykinin in man. Br J Clin Pharmacol (1987) 1.46
European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy (2012) 1.44
Central hypotensive effect of propranolol in the rabbit. Br J Pharmacol (1973) 1.44
Surgical treatment of emphysema. Br Med J (1966) 1.44
The importance of central adrenergic neurones in renal hypertension in rabbits. J Physiol (1974) 1.43
Increased sensitivity and accuracy of phaeochromocytoma diagnosis achieved by use of plasma-adrenaline estimations and a pentolinium-suppression test. Lancet (1981) 1.42
Hypertension in the young. Q J Med (1967) 1.42
Cerebral mass lesions in patients with AIDS. BMJ (1990) 1.40
An academy of medicine: a future for British postgraduate medicine? Br J Hosp Med (1995) 1.39
Atenolol in essential hypertension. Clin Pharmacol Ther (1976) 1.38
Effect of raised intraocular pressure on the retinal and choroidal circulation. Invest Ophthalmol (1968) 1.38
Metabolism of isoprenaline in dog and man. Br J Pharmacol (1972) 1.38
Drug concentration in saliva. Clin Pharmacol Ther (1978) 1.38
Experimental retinal branch vein occlusion in rhesus monkeys. I. Clinical appearances. Br J Ophthalmol (1979) 1.37
Live-epikeratophakia for keratoconus. J Cataract Refract Surg (1998) 1.35
Formation of endothelin by cultured airway epithelial cells. FEBS Lett (1989) 1.34
Metabolism of isoprenaline after aerosol and direct intrabronchial administration in man and dog. Br J Pharmacol (1974) 1.32
Environmental factors affecting paracetamol metabolism in London factory and office workers. Br J Clin Pharmacol (1980) 1.32
Deaths associated with inhalant abuse in Virginia from 1987 to 1996. Drug Alcohol Depend (1999) 1.31
Disk diffusion testing, quality control guidelines, and antimicrobial spectrum of HR810, a fourth-generation cephalosporin, in clinical microbiology laboratories. J Clin Microbiol (1984) 1.30
Metabolic alterations mediated by 2-ketobutyrate in Escherichia coli K12. Mol Gen Genet (1984) 1.29
Concentration of (+/-)-propranolol in isolated, perfused lungs of rat. Br J Pharmacol (1976) 1.29
Release of prostacyclin in vivo and its role in man. Lancet (1983) 1.27
Central noradrenergic neurones and the cardiovascular actions of clonidine in the rabbit. Br J Pharmacol (1973) 1.27
Histamine is released from skin by substance P but does not act as the final vasodilator in the axon reflex. Br J Pharmacol (1986) 1.27
alpha 1-Adrenergic receptors in guinea pig myocardium: identification by binding of a new radioligand, (3H)-prazosin. Biochem Biophys Res Commun (1979) 1.26
Streptokinase in central retinal vein occlusion: a controlled clinical trial. Br Med J (1976) 1.26
Adrenaline and hypertension. Clin Exp Hypertens A (1984) 1.26
Clinical trials of new drugs. J R Coll Physicians Lond (1977) 1.25
Postmarketing surveillance of enalapril. II: Investigation of the potential role of enalapril in deaths with renal failure. BMJ (1988) 1.25
History and modern concepts in surface replacement. Proc Inst Mech Eng H (2006) 1.24
2-Ketobutyrate: a putative alarmone of Escherichia coli. Mol Gen Genet (1983) 1.22
Indications and results of hip resurfacing. Int Orthop (2010) 1.22
Deterioration of glucose tolerance in hypertensive patients on prolonged diuretic treatment. Lancet (1976) 1.21
Methyldopa and haemolytic anaemia. Lancet (1966) 1.21
Physiological and pharmacological interactions of antihypertensive drugs. Proc R Soc Med (1965) 1.20
A truncated intracellular HER2/neu receptor produced by alternative RNA processing affects growth of human carcinoma cells. Mol Cell Biol (1993) 1.20
A specific radioenzymatic assay for dihydroxyphenylalanine (DOPA). Plasma dopa may be the precursor of urine free dopamine. Br J Clin Pharmacol (1981) 1.19
Initial care of hypertensive patients. Influence of different types of clinical records. Br Heart J (1977) 1.18
The clinical pharmacology of beta-adrenoceptor-blocking drugs. Prog Cardiovasc Dis (1977) 1.18
Hydralazine, antinuclear antibodies, and the lupus syndrome. Br Med J (Clin Res Ed) (1982) 1.17